The Luseogliflozin Market size is expected to grow at an annual average of 5% during 2021-2027. Luceogliflozin lowers plasma glucose concentrations and body weight in patients with type 2 diabetes and has beneficial effects on other clinically relevant parameters including blood pressure and uric acid. Although the safety profile was good in clinical trials, there may […]
